The new test provides physicians and their patients an objective datapoint to help determine appropriate timing for booster vaccine doses and making informed decisions related to potential COVID-19 exposure. Understanding your level of immunity can provide peace of mind as we move past the pandemic." "The COVID-19 Immune Index™ provides an accurate report for those who are immunocompromised, at risk with co-morbidities, re-entering the workplace or traveling. Guidance is constantly changing, but good tools to help people better understand their immune status have not been available," says Kevin Lawson, President and CEO of KSL. "There is a lot of variability in antibody levels over time after infection, vaccination and boosters. Recognizing that people have a need to clearly understand their level of risk for COVID-19 infection and potential complications, KSL designed and developed a new, highly accurate test that measures antibodies specific to COVID-19 which develop in response to vaccination or infection and correlates these results with virus neutralization studies incorporating the significant COVID-19 virus strains to date. This new assay correlates COVID-19 virus neutralization against a person’s antibody levels. Tests can be ordered at or (Graphic: Business Wire) Patients can now better understand their immune status to help determine appropriate timing for booster vaccine doses and making informed decisions related to potential COVID-19 exposure. The COVID-19 Immune Index™ can help monitor effectiveness of COVID-19 virus protection through a simple blood test. has launched a first-of-its-kind antibody test that detects an individual’s immune response to COVID-19 and assesses the risk of infection.
0 kommentar(er)
